Sector portfolio · VC firm · France

Sofinnova Partners' Biotech portfolio

Sofinnova Partners has backed 66 Biotech startups in rounds we track, $5.9B between them, shown by the stage each has reached. The best-funded is Abivax.

66startups backed
6stages
$5.9Braised between them
Series Abiggest stage

Sofinnova Partners's whole portfolioSofinnova Partners's profile

Series A

21

Stage not reported

15

Series B

13

Series C and later

8

Pre-seed and seed

6

Growth

3

Segment by segment

Series A

21 startups · $1.3B raised

  1. CPCinCor PharmaCinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.United States$275M
  2. BPBionyra PharmaFrance$165M
  3. Redx PharmaRedx Pharma is a drug discovery and development company.United Kingdom$127M
  4. Myricx BioMyricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.United Kingdom$115M
  5. Alethio TherapeuticsAlethio Therapeutics is a preclinical-stage biotechnology company based in Abingdon Science Park near Oxford, UK.United Kingdom$98M
  6. Mnemo TherapeuticsMnemo Therapeutics is a biotechnology company based in Paris, founded in 2019.France$90M
  7. ActitheraActithera is a biotechnology company focused on developing next-generation radioligand therapies (RLTs) for cancer treatment.United Kingdom$76M
  8. AAccentUnited States$40M

Stage not reported

15 startups · $1.5B raised

  1. AbivaxAbivax develops medicines that alter the body's natural immune system mechanisms.France$793M
  2. Tenpoint TherapeuticsTenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.United Kingdom$150M
  3. MISSION TherapeuticsMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and developmeUnited Kingdom$113M
  4. AFYRENAFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.France$98M
  5. ProQR TherapeuticsChanging lives is what drives us at ProQR Therapeutics.Netherlands$68M
  6. HAYA TherapeuticsHAYA Therapeutics, SA is a precision medicine and biotechnology company focused on developing innovative genomic medicines.Switzerland$67M
  7. InotremInotrem is a French biotechnology company founded in 2013, based in Paris with a technology center in Nancy.France$66M
  8. IInventivaFrance$44M

Series B

13 startups · $1.5B raised

  1. T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
  2. Mediar TherapeuticsMediar Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2018-2019.United States$161M
  3. Noema PharmaNoema Pharma is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 by George Garibaldi and Luigi Costa.Switzerland$147M
  4. AAVantgarde BioAAVantgarde Bio is developing gene therapies for inherited retinal disorders.Italy$141M
  5. GlycoEraGlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.Switzerland$130M
  6. Purespring TherapeuticsPurespring Therapeutics is a clinical-stage company based in London, focused on precision nephrology.United Kingdom$128M
  7. NodTheraNodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.United Kingdom$109M
  8. MironidMironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.United Kingdom$99M

Series C and later

8 startups · $894M raised

  1. HemabHemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.Denmark$157M
  2. HotSpot TherapeuticsHotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.United States$145M
  3. APAmolyt PharmaAmolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.France$139M
  4. TTISSIUMFrance$131M
  5. Green BiologicsGreen Biologics offers fermentation technologies for the conversion of biomass to renewable fuels and chemicals.United Kingdom$118M
  6. Shockwave MedicalShockwave Medical is a medical device company that develops Intravascular Lithotripsy (IVL) for treating calcified coronary diseases.United States$88M
  7. SynthaceSynthace is a London-based life sciences software company founded in 2011.United Kingdom$64M
  8. ENYO PharmaENYO Pharma is a clinical-stage biopharmaceutical company based in Lyon, France.France$54M

Pre-seed and seed

6 startups · $58M raised

  1. Cure51Cure51 is a Paris-based TechBio company founded in 2021, focused on creating a global clinical and multi-omics database of exceptiFrance$16M
  2. Home BiosciencesHome Biosciences is a biotechnology venture builder based in Paris, established in 2019.France$15M
  3. Signadori BioSignadori Bio is the next-generation cellular immunotherapy for cancer cure.France$13M
  4. BioCorteXBioCorteX is a techbio company based in London, UK, founded in March 2021.United Kingdom$5.0M
  5. Alia TherapeuticsAlia Therapeutics is an innovative biotechnology company based in Trento, Italy, founded in October 2018.Italy$4.8M
  6. EEnobraQEnobraQ is a Toulouse-based biotechnology company.France$3.6M

Growth

3 startups · $725M raised

  1. CellCentricCellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.United Kingdom$525M
  2. Innate PharmaInnate Pharma S.A.France$134M
  3. ArzedaWe harness the power of Intelligent Protein Design TechnologyTM to create enzyme products solving industry's toughest challengesUnited States$65M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Sofinnova Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapSofinnova Partners portfolio map105 startups · $7.4BCo-investorsWho invests with Sofinnova Partners65 co-investorsInvestments abroadSofinnova Partners' investments in the United States20 startups · $1.1BSector portfolioKima Ventures' AI portfolio79 startups · $975MSector portfolioKima Ventures' IT Services portfolio55 startups · $233MSector portfolioKima Ventures' Fintech portfolio42 startups · $2.6B

Raising from investors like Sofinnova Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps